FDA

The pharma company claims a previous decision to discontinue research into the drug was based on incomplete Phase 3 trial data and new analysis has revealed significant success

Medical

Drug slowing Alzheimer’s dementia unexpectedly moves to FDA submission

In an unusual turn of events a new Alzheimer’s drug, previously declared a failure in March, has been resurrected with the pharmaceutical company behind the treatment suggesting the earlier decision was premature and based on incorrect data analysis.

The CDC reports 33 confirmed deaths connected to e-cigarette lung injury

Health & Wellbeing

Vaping crisis nears 1,500 cases, Juul pulls some e-cig flavors

A new update on the ongoing vaping crisis has revealed nearly 1,500 lung injury cases have been identified, with 33 confirmed deaths. Alongside this news, Juul announced it is suspending sales of four popular e-cigarette flavors pending FDA review.

A treatment for peanut allergies is on a path to be approved and on the market by early 2020

Health & Wellbeing

Peanut allergy treatment approved by FDA advisory panel

The first oral immunotherapy agent to treat peanut allergy is set to be approved, but questions still remain over how effective and long-lasting it is.

A Trump administration announcement tasks the FDA with enforcing guidelines that restrict the sale of unapproved flavored e-cigarettes, effectively banning the products in the United States

Health & Wellbeing

Trump moves to ban flavored e-cigarette liquids across US

Amid the e-cigarette health crisis in the US, the Trump administration announced a plan to ban all non-tobacco-flavored e-cigarette products.

A render of the Canady Helios Cold Plasma System and Scalpel, which has just been approved by the FDA for use in a clinical trial against cancer

Medical

FDA approves clinical trial of cold plasma "scalpel" for cancer treatment

A cold atmospheric plasma system designed to prevent cancer relapse has been approved for human clinical trials by the FDA.

MMS, an alleged miracle cure, is already banned in a number of countries, and is essentially an industrial bleaching agent

Health & Wellbeing

Miracle Mineral Solution, aka industrial bleach, is no autism cure, FDA warns

The FDA is again warning the public to avoid consuming a product called Miracle Mineral Solution (MMS). Despite over a decade of health warnings and cases of death, the sham product, which is essentially bleach, is still being consumed as a miracle cure for everything from autism to cancer and HIV.

The FDA claims a Novartis subsidiary was aware there was inaccurate data in its application before the final approval was granted

Medical

Pharma giant admits data manipulation in FDA application for multi-million-dollar gene therapy

A newly published statement from the US Food & Drug Administration (FDA) has revealed inaccurate, intentionally manipulated data was included as part of a submission for a major new gene therapy that was approved for public use in May.

Hospitalizations of teenagers displaying severe lung diseasea has sparked a new wave of health concerns around e-cigarette use

Health & Wellbeing

At least 11 hospitalizations and 127 seizures linked to vaping, as FDA investigates

The Wisconsin Department of Health Services is reporting a number of hospitalizations of teenagers displaying severe lung disease, with suspicions of links to e-cigarette use. The FDA has also recently revealed it has accumulated 127 reports of seizures claimed to be related to e-cigarette use.

The FDA approval was the final hurdle holding Impossible Foods back from entering the direct-to-consumer grocery store market

Science

Key Impossible Burger ingredient finally approved by FDA for direct-to-consumer sales

Impossible Foods’ plant-based meat alternative will finally be hitting grocery stores in the United States. The FDA has approved its key additive allowing Impossible Foods to move from only selling its products in restaurants and into supermarkets across the country.

The FDA is trying to speed up its work to institute regulatory policies surrounding the rapidly growing CBD market while several companies sell products with unproven medical claims

Health & Wellbeing

FDA cracks down on rogue CBD products touting unproven health claims

The FDA is cracking down on a number of companies selling cannabidiol (CBD) products accompanied by unsubstantiated health claims. The latest target is a company called Curaleaf, which sells CBD products claimed to treat everything from cancer and Alzheimer’s, to anxiety and inflammation in dogs.

Several in a new class of drugs designed to treat rheumatoid arthritis are inching closer to the market following successful final phase human trial results

Medical

Experimental new rheumatoid arthritis drug passes final phase of human trials

A novel experimental drug is showing promising results from its final phase of human clinical trials. Part of a new class of drugs called JAK-inhibitors, this therapy targets rheumatoid arthritis sufferers and is hoped to be approved for use by the FDA within the next 12 months.

The FDA has approved a new type of cancer drug called selinexor

Medical

FDA approves risky new type of cancer drug – with caveats

The FDA has granted accelerated approval to a new cancer drug called selinexor. This pill has been found to be successful in treating multiple myeloma in patients that hadn’t had success with other treatments. But at this very early stage the drug comes with some major caveats.